Miscarriage Clinical Trials 2023

Browse 1 Miscarriage Medical Studies Across 1 Cities
1 Miscarriage Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Miscarriage Clinical Trials 2023

Reviewed by Michael Gill, B. Sc.

Image of Reprogenetics in Livingston, United States.

Next Generation Sequencing After Blastocyst Biopsyfor Infertility

18 - 42

Female

Livingston, NJ

This trial will compare the effectiveness of a new method of embryo selection (NGS) to the standard method (ART) in terms of implantation rates, miscarriage rates, and pregnancy rates.

Phase 2

Waitlist Available

Has No Placebo

ReprogeneticsSantiago Munne, PhDReprogenetics

1 Miscarriage Clinical Trials Near Me

Top Hospitals for Miscarriage Clinical Trials

Reprogenetics

Livingston

1Active Trials

0All Time Trials for Miscarriage

2023First Miscarriage Trial

Top Cities for Miscarriage Clinical Trials

Livingston

1Active Trials

ReprogeneticsTop Active Site

Miscarriage Clinical Trials by Phase of Trial

Phase 2 Miscarriage Clinical Trials

1Active Miscarriage Clinical Trials

1Number of Unique Treatments

1Number of Active Locations

Next Generation Sequencing after Blastocyst biopsy

Miscarriage Clinical Trials by Age Group

18 - 65 Miscarriage Clinical Trials

1Active Miscarriage Clinical Trials

Next Generation Sequencing after Blastocyst biopsy

Most Recent Miscarriage Clinical Trials

Clinical Trial

Began Recruiting Date

Phase

Next Generation Sequencing after Blastocyst biopsy for Infertility

9/1/2013

Phase 2

Top Treatments for Miscarriage Clinical Trials

Treatment Name

Active Miscarriage Clinical Trials

All Time Trials for Miscarriage

First Recorded Miscarriage Trial

Next Generation Sequencing after Blastocyst biopsy

2013

Recently Completed Studies with FDA Approved Treatments for Miscarriage

Treatment

Year

Sponsor

Ulipristal Acetate Tablets

2022

University of North Carolina, Chapel Hill

Uterine ERA and microbiome testing

2017

Stanford University

About The Author

Michael Gill - B. Sc.

First Published: October 5th, 2021

Last Reviewed: August 3rd, 2023

References¹ Cornelisse S, Zagers M, Kostova E, Fleischer K, van Wely M, Mastenbroek S. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation. Cochrane Database Syst Rev. 2020 Sep 8;9:CD005291. doi: 10.1002/14651858.CD005291.pub3. https://pubmed.ncbi.nlm.nih.gov/32898291² Cornelisse S, Zagers M, Kostova E, Fleischer K, van Wely M, Mastenbroek S. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation. Cochrane Database Syst Rev. 2020 Sep 8;9(9):CD005291. doi: 10.1002/14651858.CD005291.pub3. https://pubmed.ncbi.nlm.nih.gov/32898291³ Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, Treff NR, Scott RT Jr. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013 Jul;100(1):100-7.e1. doi: 10.1016/j.fertnstert.2013.02.056. Epub 2013 Mar 30. https://pubmed.ncbi.nlm.nih.gov/23548942⁴ Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, Peck AC, Sills ES, Salem RD. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet. 2012 May 2;5(1):24. doi: 10.1186/1755-8166-5-24. https://pubmed.ncbi.nlm.nih.gov/22551456⁵ Munne S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril. 2010 Jul;94(2):408-30. doi: 10.1016/j.fertnstert.2009.02.091. Epub 2009 May 5. https://pubmed.ncbi.nlm.nih.gov/19409550⁶ Gutiérrez-Mateo C, Colls P, Sánchez-García J, Escudero T, Prates R, Ketterson K, Wells D, Munné S. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril. 2011 Mar 1;95(3):953-8. doi: 10.1016/j.fertnstert.2010.09.010. Epub 2010 Oct 25. https://pubmed.ncbi.nlm.nih.gov/20971462⁷ Munné S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril. 2010 Jul;94(2):408-30. doi: 10.1016/j.fertnstert.2009.02.091. Epub 2009 May 5. Review. https://pubmed.ncbi.nlm.nih.gov/19409550⁸ Gutierrez-Mateo C, Colls P, Sanchez-Garcia J, Escudero T, Prates R, Ketterson K, Wells D, Munne S. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril. 2011 Mar 1;95(3):953-8. doi: 10.1016/j.fertnstert.2010.09.010. Epub 2010 Oct 25. https://pubmed.ncbi.nlm.nih.gov/20971462⁹ Cohen J, Wells D, Munné S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril. 2007 Mar;87(3):496-503. Epub 2006 Dec 4. https://pubmed.ncbi.nlm.nih.gov/17141767¹⁰ De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, Liebaers I, Van de Velde H. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod. 2009 Dec;24(12):2988-96. doi: 10.1093/humrep/dep251. Epub 2009 Sep 21. https://pubmed.ncbi.nlm.nih.gov/19773223